As part of the development process, our nuclear medicine investigational products are evaluated in clinical trials to find new and better ways to diagnose and treat disease. These studies may be sponsored by Advanced Accelerator Applications (AAA) or by independent investigators/physicians at medical centers.
Products tested in clinical trials may not be approved by health authorities, or they may be approved for certain indications but being tested to determine if they are useful in other conditions. Patients should discuss their potential participation in such studies with their physician. The table below lists oncology clinical trials and non-oncology clinical trials with our investigational products.